Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00695747 · ClinicalTrials.gov registry record · NA

Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy

A NA study of Glaucoma and Cataracts, sponsored by Lahey Clinic.

Completed
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT00695747 is a NA study of Glaucoma and Cataracts that has completed, run by Lahey Clinic. The registered enrollment target is 95 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00695747, a NA study of Glaucoma and Cataracts, has completed, sponsored by Lahey Clinic.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the safety \& effectiveness of the two types of cataract and glaucoma surgeries. Results from this study may improve the surgical and post surgical management and long term management of patients with these conditions in the future

Conditions Studied

Interventions

  • PROCEDURE 2 Site procedure- Phacoemulsification/IOL and Trabeculectomy

Study Locations (1)

Massachusetts

  • Lahey Clinic, Inc. - Burlington

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 1998-01
Est. Completion 2009-01
Phase NA

Sponsor

Lahey Clinic

43 total trials

What the Registry Record Tells You About NCT00695747

The ClinicalTrials.gov registry entry for NCT00695747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (90% lower). The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which 2 Site procedure- Phacoemulsification/IOL and Trabeculectomy is the first listed.

NCT00695747 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00695747 about?

NCT00695747 is a clinical study titled "Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy". The purpose of this study is to compare the safety \& effectiveness of the two types of cataract and glaucoma surgeries. Results from this study may improve the surgical and post surgical management and long term management of patients with these conditions in the future

What is the current status of trial NCT00695747?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 1998-01. Estimated completion is 2009-01.

What conditions does trial NCT00695747 study?

This clinical trial studies the following conditions: Glaucoma, Cataracts.

What interventions are being tested in trial NCT00695747?

The interventions under investigation include: 2 Site procedure- Phacoemulsification/IOL and Trabeculectomy (PROCEDURE).

Who is sponsoring clinical trial NCT00695747?

This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00695747 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.